Anti-Tetanus toxoid Antibody

Polyclonal antibodies from Antibodies.com are raised in goat hosts against tetanus toxoid, the formaldehyde-inactivated derivative of Clostridium tetani neurotoxin that forms the antigenic core of standard tetanus vaccines. This unconjugated primary reagent is supplied as a purified Ig fraction in a 500 µl vial, prepared for direct deployment across ELISA, immunofluorescence assay (IFA), Western blot, and immunohistochemistry workflows. Researchers apply it to characterize toxoid antigenicity, evaluate vaccine potency in release testing, or profile humoral responses in immunization studies. The polyclonal format recognizes multiple epitopes across the toxoid molecule, providing broader reactivity than monoclonal alternatives when conformational determinants are under investigation. With no conjugate attached, the antibody pairs flexibly with HRP-, biotin-, or fluorophore-labeled secondary reagents selected by the investigator for each detection platform. Aliquoting upon receipt and limiting freeze-thaw cycles helps preserve binding activity across extended projects.